182 related articles for article (PubMed ID: 9401063)
1. Platelet activity of high-dose factor VIIa is independent of tissue factor.
Monroe DM; Hoffman M; Oliver JA; Roberts HR
Br J Haematol; 1997 Dec; 99(3):542-7. PubMed ID: 9401063
[TBL] [Abstract][Full Text] [Related]
2. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
[TBL] [Abstract][Full Text] [Related]
3. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
Hoffman M; Monroe DM; Oliver JA; Roberts HR
Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
[TBL] [Abstract][Full Text] [Related]
4. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets.
Monroe DM; Hoffman M; Roberts HR
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):459-64. PubMed ID: 8839998
[TBL] [Abstract][Full Text] [Related]
5. Factor VIIa-mediated tenase function on activated platelets under flow.
Goel MS; Diamond SL
J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
[TBL] [Abstract][Full Text] [Related]
7. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Wong PC; Jiang X
Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood.
Gerotziafas GT; Depasse F; Chakroun T; Samama MM; Elalamy I
Thromb Haemost; 2004 Mar; 91(3):531-7. PubMed ID: 14983229
[TBL] [Abstract][Full Text] [Related]
9. Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.
Stavenuiter F; Davis NF; Duan E; Gale AJ; Heeb MJ
Thromb Haemost; 2013 Feb; 109(2):229-37. PubMed ID: 23238804
[TBL] [Abstract][Full Text] [Related]
10. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.
Hoffman M; Monroe DM; Roberts HR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S61-5. PubMed ID: 9819030
[TBL] [Abstract][Full Text] [Related]
11. A possible mechanism of action of activated factor VII independent of tissue factor.
Monroe DM; Hoffman M; Oliver JA; Roberts HR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S15-20. PubMed ID: 9819024
[TBL] [Abstract][Full Text] [Related]
12. Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist.
Kjalke M; Kjellev S; Rojkjaer R
J Thromb Haemost; 2007 Apr; 5(4):774-80. PubMed ID: 17229056
[TBL] [Abstract][Full Text] [Related]
13. Platelet procoagulant complex assembly in a tissue factor-initiated system.
Monroe DM; Roberts HR; Hoffman M
Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
[TBL] [Abstract][Full Text] [Related]
14. Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity.
Fager AM; Machlus KR; Ezban M; Hoffman M
J Thromb Haemost; 2018 Sep; 16(9):1817-1829. PubMed ID: 29879294
[TBL] [Abstract][Full Text] [Related]
15. Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa.
Knudsen T; Kjalke M; Tranholm M; Nichols TC; Jensen AL; Kristensen AT
Am J Vet Res; 2011 Aug; 72(8):1007-14. PubMed ID: 21801056
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
Rao LV; Ruf W
Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
Sultan Y; Loyer F
J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived microvesicles and activated platelets express factor Xa activity.
Holme PA; Brosstad F; Solum NO
Blood Coagul Fibrinolysis; 1995 Jun; 6(4):302-10. PubMed ID: 7548677
[TBL] [Abstract][Full Text] [Related]
19. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
[TBL] [Abstract][Full Text] [Related]
20. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor.
Kakkar AK; DeRuvo N; Chinswangwatanakul V; Tebbutt S; Williamson RC
Lancet; 1995 Oct; 346(8981):1004-5. PubMed ID: 7475548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
